Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
Stock Snapshot
With a market cap of 208.02B, Novo Nordisk(NVO) trades at $45.87. The stock has a price-to-earnings ratio of 13.29 and currently yields dividends of 2.7%.
On 2025-11-08, Novo Nordisk(NVO) stock moved within a range of $45.15 to $46.88. With shares now at $45.87, the stock is trading +1.6% above its intraday low and -2.2% below the session's peak.
Trading activity shows a volume of 19.98M, compared to an average daily volume of 21.45M.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $45.05.
NVO News
Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover battle for obesity drug developer Metsera Inc....
Healthcare M&A Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal Nov. 08, 2025 6:42 AM ET Pfizer Inc. (PFE) Stock, NVO Stock, MTSR Stock, NONOF...
Pfizer Inc. (NYSE:PFE) secured a $10 billion deal to acquire obesity drug developer Metsera, Inc. (NASDAQ:MTSR), beating out Novo Nordisk A/S (NYSE:NVO) after a...
Analyst ratings
63%
of 32 ratingsMore NVO News
(RTTNews) - Metsera Inc. (MTSR) announced that it has entered into an amended merger agreement with Pfizer, under which Pfizer will acquire Metsera for up to $8...
New On The Block Miyoko Schinner — the chef and activist who pioneered artisanal vegan cheese — is mounting a bid to buy back Miyoko's, the plant-based dairy b...
Below is Validea's guru fundamental report for NOVO NORDISK A/S (ADR) (NVO). Of the 22 guru strategies we follow, NVO rates highest using our Patient Investor m...
Key Points President Donald Trump struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in access to their costly blockbuster ob...
The global drugmaker is facing some headwinds related to tough competition. The stock price for Danish drugmaker Novo Nordisk (NVO 1.77%) is down more than 8%...
Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to tre...
Wall Street enjoyed a guilt-free feast in 2024 as shares of Novo Nordisk (NVO), Eli Lilly (LLY) and other makers of weight-loss drugs skyrocketed. But a shift i...
